Impact of CFTR modulators on exercise capacity in adolescents with cystic fibrosis.

In children who were initially treated with Symkevi and then switched to Kaftrio, there were additional small improvements noted in most parameters, but these did not reach statistical significance likely due to small patient numbers.

also in 111,027 other papers